Breast cancer and trisomy 21: a new publication for the Jérôme Lejeune Institute
Posté le 24 July 2020.
Breast cancer and trisomy 21: a new publication for the Jérôme Lejeune Institute A study on the link between breast cancer and trisomy 21, conducted by a team of researchers from the Institut Jérôme Lejeune, using biological resources from the CRB-BioJeL*, has just been published in the journal Scientific Reports*. This study is based on […]
Lire la suite...
Methylomic profiling in trisomy 21 identifies cognition and Alzheimer’s disease-related dysregulation
Posté le 9 March 2020.
Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation A study on DNA methylation at the genome level has just been carried out in partnership with the CRB BioJeL, the Institut Jérôme Lejeune and the Institute of Human Genetics of the University of Würzburg in Germany. This study confirms that Trisomy 21 patients […]
Lire la suite...